Does blood glucose level have influence on 18F-FDG metabolic indices in normal and neoplastic tissues

Estimation of The Patient’s Specific Effective Dose for The Total Body F18- FDG PET/CT Scan, A Single Centre Experience

Prognostic Value of F-18 FDG PET/CT Volume-Based Metabolic Parameters in Patients with Cancer Esophagus.

Factors Affecting the Metabolic Parameters Measured by 18F FDG PET/CT in Initial Assessment of Lymphoma Patients

Diagnostic Performance of Semi-Quantitative Metabolic Parameters on 18F-FDG PET/CT in the Axillary Staging of Breast Cancer Patients.

Value of F-18 FDG PET/CT Compared to Conventional Imaging in changing management of Patients with Differentiated Thyroid Cancer before radioactive iodine ablation.

Value of Initial 18F-FDG PET/CT in Change of Management of Patients with Differentiated Thyroid Cancer as Compared to Post Ablative Whole Body Iodine Scan.

Fluorine-18-Fluorodeoxyglucose-Avid Thyroid Incidentalomas on Positron Emission Tomography/Computed Tomography in Patients with Non-Thyroid Malignancy: Incidence and Possible Nature

Evaluation of Incidental Thyroid Findings Detected by Positron Emission Tomography/Computed Tomography

The Effects of TSH level on the Results of F-18 FDG PET/CT in Recurrent Differentiated Thyroid Carcinoma Patients with Elevated Serum Thyroglobulin Level and Negative I-131 WBS.